EW
MYOK

Evoke Wealth’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Evoke Wealth’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-33
Closed -$1.55K – 1244
2020
Q1 		$1.55K Sell
33
-43
-57% -$2.75K ﹤0.01% 851
2019
Q4 		$5.54K Buy
76
+43
+130% +$2.61K ﹤0.01% 891
2019
Q3 		$1.72K Buy
+33
New +$1.75K ﹤0.01% 1235

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Evoke Wealth's MYOK Position: Q2 2020 in Review

Evoke Wealth sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 33 shares — an estimated $1.55K sold.

Evoke Wealth first reported a position in MYOK in Q3 2019 and held it in 3 quarters. The position peaked at $5.54K in Q4 2019. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

  • Evoke Wealth reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Evoke Wealth sold 33 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $1.55K.
  • Evoke Wealth first reported a position in MyoKardia, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Evoke Wealth's MyoKardia, Inc. Common Stock position peaked at $5.54K in Q4 2019.
  • 235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Evoke Wealth's 13F filing for Q2 2020, filed 10 Aug 2020.